MedTrace Logo

Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes

NCT07214155 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-05-22

No results posted yet for this study

Summary

This study will evaluate the subjective and behavioral effects of cannabis products labeled as indica, sativa, or generic.

Conditions

  • Cannabis Intoxication

Interventions

DRUG

Cannabis

Cannabis will be administered via smoked inhalation.

OTHER

0 mg THC (placebo)

0 mg THC (placebo)

Sponsors & Collaborators

Principal Investigators

  • Carlos A Zamarripa, PhD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-15
Primary Completion
2029-06-30
Completion
2029-09-30
FDA Drug
Yes

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07214155 on ClinicalTrials.gov